Seo et al. [5] pointed out that, although inhibiting ANO1 appears beneficial in diminishing both proliferation and migration within prostate cancer cells, the specific signaling pathways by which TMEM16A enacts these effects are not entirely clarified. Here, ANO1 is linked to prostate carcinoma.